GHO Capital Partners Mergers and Acquisitions Summary

Private Equity Firm Profile

In the last 3 years, GHO Capital Partners has acquired 8 companies. It has also invested in 1 other.

GHO Capital Partners’ most common sectors for investment arelife science (79%) and business services (8%) . The Firm’s most common investment types include secondary buyout (50%) and buyout (lbo, mbo, mbi) (36%). In total, GHO Capital Partners has invested in 4 US states and 8 different countries. Its largest (disclosed) acquisition occurred in 2015 when it acquired DNA Diagnostics Center for $110M.

In the last 3 years, GHO Capital Partners has exited 3 companies. The Firm’s most common exit type is trade sale (34%).

Join Mergr to view GHO Capital Partners’ full profile and discover more small private equity firms just like it.

M&A Summary

  • M&A Total Activity17
    • M&A Buy Activity14
    • M&A Sell Activity3
  • Total Sectors Invested 4
  • Total Countries Invested 8
  • M&A Buy/Sell Connections 2
  • M&A Advisors 11

GHO Capital Partners LLP

21 St James’s Square,
London, SW1Y 4JZ
United Kingdom
+44 20 3700 7440
www.ghocapital.com
info@ghocapital.com

GHO Capital Partners is a private investment firm focused on the healthcare sector. The Firm will consider opportunities throughout Europe and seeks well-established, profitable businesses that have the potential to deliver a combination of double-digit top line growth, significant efficiency gains and international expansion. GHO Capital Partners was established in 2014 and is based in London.


Investment Criteria

Sectors of Interest: Healthcare Services, Life Science, Medical Products

Target Transaction Types: Buyout (LBO, MBO, MBI), Divestiture, Secondary Buyout

Geographic Preferences: United Kingdom, Western Europe, Eastern Europe, Scandinavia

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size - -
Enterprise Value - -

M&A Summary

Buy vs Sell

Year ≤ '16 '17 '18 '19 '20 '21 T
Buy (1.8/yr) # 5 - 4 1 3 1 14
vol $110M $110M
Sell (0.6/yr) # - - - 2 - 1 3
  17

Most Recent M&A

Company Date Value Type
DNA Diagnostics Center, Inc. 2021-06-28 - Add-on Acquisition
Fairfield, Ohio · www.dnacenter.com
Velocity Clinical Research, Inc. 2021-04-08 - Secondary Buyout
Durham, North Carolina · www.velocityclinical.com
X-Chem, Inc. 2020-06-03 - Divestiture
Waltham, Massachusetts · www.x-chemrx.com
FairJourney Biologics SA 2020-01-30 - Growth Capital
Porto, Portugal · www.fjb.pt
Ardena Holding NV 2020-01-09 - Secondary Buyout
Mariakerke, Belgium · www.ardena.com
CellCarta 2019-07-31 - Secondary Buyout
Montreal, Quebec · www.cellcarta.com
Quotient Clinical Ltd. 2019-07-18 - Recapitalization
Ruddington, United Kingdom · www.weneedyou.co.uk
Sterling Pharma Solutions 2019-02-12 - Buyout (LBO, MBO, MBI)
Northumberland, United Kingdom · www.sterlingpharmasolutions.com
Validant 2018-12-20 - Buyout (LBO, MBO, MBI)
San Francisco, California · www.validant.com
BioAgilytix Labs LLC 2018-11-02 - Secondary Buyout
Durham, North Carolina · www.bioagilytix.com
View All >>

Portfolio M&A

Company Acquired Add-On/Sale Date #
Sterling Pharma Solutions 2019-02-12 ADC Biotechnology Ltd. 2021-04-07 3
Northumberland, United Kingdom · www.sterlingpharmasolutions.com Deeside, United Kingdom · www.adcbio.com
Envision Pharma, Inc. 2016-07-06 Two Labs LLC 2020-11-12 3
Horsham, United Kingdom · www.envisionpharmagroup.com Powell, Ohio · www.twolabs.com
Sterling Pharma Solutions 2019-02-12 Alcami Corp. - API Facility 2020-10-01 2
Northumberland, United Kingdom · www.sterlingpharmasolutions.com Germantown, Wisconsin

M&A by Sector

Sector Current # Value All-time # Value
Life Science 8 (73%) - 11 (79%) 110M (100%)
Business Services 1 (9%) - 1 (7%) -
Healthcare Services 1 (9%) - 1 (7%) -
Information Technology 1 (9%) - 1 (7%) -
Total 11 - 14 $110M

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 4 (36%) - 5 (36%) 110M (100%)
  North Carolina 2 (18%) - 2 (14%) -
  Massachusetts 1 (9%) - 1 (7%) -
  California 1 (9%) - 1 (7%) -
  Ohio - - 1 (7%) 110M (100%)
United Kingdom 2 (18%) - 3 (21%) -
Germany 1 (9%) - 1 (7%) -
Spain 1 (9%) - 1 (7%) -
Belgium 1 (9%) - 1 (7%) -
Netherlands 1 (9%) - 1 (7%) -
Portugal 1 (9%) - 1 (7%) -
Canada - - 1 (7%) -
  Quebec - - 1 (7%) -
Total 11 - 14 $110M

Acquisitions by Deal Type

Type Current # Value All-time # Value
Secondary Buyout 4 (36%) - 7 (50%) 110M (100%)
Buyout (LBO, MBO, MBI) 5 (45%) - 5 (36%) -
Divestiture 1 (9%) - 1 (7%) -
Growth Capital 1 (9%) - 1 (7%) -
Total 11 - 14 $110M

Exits by Deal Type

Type Total # Value
Recapitalization 1 (33%) -
Secondary Sale 1 (33%) -
Trade Sale - Public Company 1 (33%) -
Total 3 -

Top M&A Advisors

Financial Deals
Deloitte
4
Alvarez & Marsal
2
PwC Corporate Finance LLC
1
Legal Deals
Ropes & Gray LLP
5
Loyens & Loeff N.V.
1
Sidley Austin LLP
1

Deal Values

buy # Total
$100M to $1B 1 $110M
TOTAL $110M
Largest DNA Diagnostics Center, Inc.
$110M (2015-10-13)

M&A Connections

Deals
Acquired from
Investor(s)
50%
7 (50%)
Strategic(s)
7%
1 (7%)
Exited to
Investor(s)
67%
2 (67%)
Strategic(s)
33%
1 (33%)

 Subscribe to unlock this and 169,018
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.2K Private Equity Firms
  • 158K M&A Transactions
  • 165K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.3K M&A Advisors
    (Investment Banks and Law Firms)
  • 57K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.